Ignite Creation Date:
2024-05-06 @ 8:45 AM
Last Modification Date:
2024-10-26 @ 12:04 PM
Study NCT ID:
NCT02813694
Status:
COMPLETED
Last Update Posted:
2019-10-23
First Post:
2016-06-20
Brief Title:
Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia
Sponsor:
Nabriva Therapeutics AG
Organization:
Nabriva Therapeutics AG
Organization Data
Organization:
Nabriva Therapeutics AG
Class:
INDUSTRY
Study ID:
NAB-BC-3781-3102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nabriva Therapeutics AG
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None